Compugen Ltd (Israel) Financial Diagnostics

CGEN -- Israel Stock  

ILS 1,233  93.00  7.01%

Compugen Ltd diagnostics interface makes it easy to digest most current publicly released information about Compugen Ltd as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis Compugen Ltd price relationship with some important fundamental indicators such as market cap and management efficiency.

Compugen Ltd Note

The company recorded loss per share of 0.57. Compugen Ltd had not issued any dividends in recent years. Compugen Ltd., a therapeutic discovery company, engages in the research, development, and commercialization of therapeutic and product candidates in Israel and Europe. The company was incorporated in 1993 and is headquartered in Holon, Israel. Compugen Ltd operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 101 people. For more info on COMPUGEN please contact Anat CohenDayag at 972 3 765 8585 or go to http://www.cgen.com.

Compugen Ltd Alerts

Compugen Ltd is not yet fully synchronised with the market data
Compugen Ltd generates negative expected return over the last 30 days
Compugen Ltd has high historical volatility and very poor performance
Compugen Ltd has high likelihood to experience some financial distress in the next 2 years
The company reported revenue of 10 M. Net Loss for the year was (29.27 M) with profit before overhead, payroll, taxes, and interest of 489 K.
COMPUGEN has accumulated about 42.46 M in cash with (23.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.74.
Latest headline from pressoracle.com: Compugen Ltd. Expected to Announce Earnings of -0.19 Per Share

Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 758.29 M.

Profitablity

The company has Profit Margin (PM) of (292.7) % which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (295.84) % which suggests for every $100 dollars of sales it generated a net operating loss of -2.96.

Management Efficiency

Compugen Ltd has return on total asset (ROA) of (34.67) % which means that it has lost $34.67 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (66.7) % meaning that it generated substantial loss on money invested by shareholders.

Stock Holders for Compugen Ltd

Compugen Ltd Predictive Indicators

Did you try this?

Run Crypto Portfolio Optimizer Now

   

Crypto Portfolio Optimizer

Optimize portfolio of digital coins and token across multiple currency and exchanges
All  Next Launch Crypto Portfolio Optimizer

Also Currentnly Active

Purchased over 100 shares of
a day ago
Traded for 41.84
Purchased over 100 shares of
a day ago
Traded for 28.79
Purchased over 100 shares of
a day ago
Traded for 108.66
Check also Trending Equities. Please also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Search macroaxis.com